Enfuvirtid

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

T-20

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Fusion inhibitor (entry inhibitor). Inhibitor of the fusion of HIV-1 with CD4+ target cells.

Pharmacodynamics (Effect)This section has been translated automatically.

Enfuvirtide binds to the HR1 (heptate-repeat 1) subunit of the viral glycoprotein gp 41 and thereby prevents the conformational change of gp 41 required for the infection of target cells and thus the approximation of the membranes of HIV-1 and target cell.

Notice!

Enfuvirtid is exclusively effective against HIV-1, there is no activity against HIV-2.

IndicationThis section has been translated automatically.

In combination therapies for the treatment of HIV-1 infection in experienced patients with proven virus replication (viral load) despite HAART.

Pregnancy/nursing periodThis section has been translated automatically.

Should not be used during pregnancy and lactation (insufficient data available).

Complication(s)This section has been translated automatically.

Bacterial pneumonia.

Dosage and method of useThis section has been translated automatically.

2 times/day 90 mg (1 ml) s.c.

Undesirable effectsThis section has been translated automatically.

Often local reactions at the injection site (erythema, urtica).

PreparationsThis section has been translated automatically.

Fuzeon

Authors

Last updated on: 29.10.2020